Overview

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Effects of Teriparatide in Postmenopausal Women Previously Treated with Alendronate or Raloxifene.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Raloxifene Hydrochloride
Teriparatide